DrugPatentWatch Database Preview
Mometasone furoate - Generic Drug Details
What are the generic sources for mometasone furoate and what is the scope of mometasone furoate patent protection?
Mometasone furoate
is the generic ingredient in six branded drugs marketed by Merck Sharp Dohme, Fougera Pharms, G And W Labs, Glenmark Generics, Taro, Tolmar, Intersect Ent Inc, Perrigo Israel, Perrigo New York, Torrent Pharms Ltd, Amneal Pharms, and Apotex Inc, and is included in twenty-seven NDAs. There are thirteen patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.There are twenty-nine drug master file entries for mometasone furoate. Twenty-one suppliers are listed for this compound.
Summary for mometasone furoate
| US Patents: | 13 |
| Tradenames: | 6 |
| Applicants: | 12 |
| NDAs: | 27 |
| Drug Master File Entries: | 29 |
| Suppliers / Packagers: | 21 |
| Bulk Api Vendors: | 56 |
| Clinical Trials: | 92 |
| Patent Applications: | 6,459 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for mometasone furoate |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for mometasone furoate |
| DailyMed Link: | mometasone furoate at DailyMed |
Pharmacology for mometasone furoate
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for mometasone furoate
Synonyms for mometasone furoate
| (11beta,16alpha)-9,21-dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate |
| (11beta,16alpha)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione |
| (1R,2S,10S,11S,13R,14R,15S,17S)-1-CHLORO-14-(2-CHLOROACETYL)-17-HYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL FURAN-2-CARBOXYLATE |
| (8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate |
| (9beta,10alpha,11alpha,14beta,16alpha,17alpha)-9,21-dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate |
| [(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloranyl-17-(2-chloranylethanoyl)-10,13,16-trimethyl-11-oxidanyl-3-oxidanylidene-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate |
| [(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate |
| 04201GDN4R |
| 11?,16?)-9,21-Dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl 2-furoate |
| 2-furancarboxylic acid [(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloro-1-oxoethyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] ester |
| 83919-23-7 |
| 9,21-dichloro-11beta-hydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate |
| 9,21-Dichloro-11beta,17-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17-(2-furoate) |
| 919M237 |
| A840685 |
| AB2000407 |
| AC-941 |
| AC1L9AZS |
| AK163902 |
| AKOS015994732 |
| AN-15438 |
| Asmanex |
| Asmanex HFA |
| Asmanex Twisthaler |
| BC228151 |
| BDBM50148733 |
| BPBio1_000424 |
| BRD-K60640630-001-03-7 |
| BRN 4340538 |
| BSPBio_000384 |
| C07817 |
| C27H30Cl2O6 |
| CAS-83919-23-7 |
| CCG-220572 |
| CHEBI:47564 |
| CHEMBL1161 |
| CS-2389 |
| D00690 |
| Danitin |
| DR003147 |
| DSSTox_CID_3333 |
| DSSTox_GSID_23333 |
| DSSTox_RID_76981 |
| DTXSID4023333 |
| Ecural |
| Elocon |
| Elocone |
| Elomet |
| Flumeta |
| HMS1569D06 |
| HMS2096D06 |
| HMS2235I14 |
| HY-13693 |
| KS-00000SPL |
| KS-1275 |
| LAS 41002 |
| M2354 |
| MLS002153879 |
| MolPort-003-849-257 |
| Mometasone 17-(2-furoate) |
| mometasone 17-furoate |
| mometasone furancarboxylate |
| Mometasone furoate (JAN/USP) |
| Mometasone furoate [USAN:USP:JAN] |
| Mometasone furoate hydrate |
| Mometasone Furoate Impurity G |
| MOMETASONE FUROATE MONOHYDRATE |
| Mometasone furoate, >=98% (HPLC) |
| Mometasone furoate, European Pharmacopoeia (EP) Reference Standard |
| Mometasone Furoate, pharmaceutical secondary standard; traceable to USP, PhEur and BP |
| Mometasone furoate, United States Pharmacopeia (USP) Reference Standard |
| Monovo |
| Nasonex |
| NCGC00016950-01 |
| NCGC00179578-01 |
| NCGC00179578-03 |
| NCGC00179578-04 |
| Nosorex |
| NSC-746171 |
| NSC746171 |
| Ovixan |
| PL071566 |
| Pregna-1,20-dione, 9,21-dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methyl-, (11.beta.,16.alpha.)- |
| Pregna-1,4-diene-3,20-dione, 9,21-dichloro-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methyl-, (11beta,16alpha)- |
| Prestwick_924 |
| Prestwick0_000572 |
| Prestwick1_000572 |
| Prestwick2_000572 |
| Prestwick3_000572 |
| Q-101380 |
| Rimelon |
| s1987 |
| Sch 32088 |
| Sch-32088 |
| SCHEMBL4568 |
| Sinuva |
| SMR001233233 |
| SPBio_002603 |
| SR-01000841209 |
| SR-01000841209-2 |
| ST24048112 |
| TL8005500 |
| Tox21_110705 |
| Tox21_110705_1 |
| UNII-04201GDN4R |
| WOFMFGQZHJDGCX-ZULDAHANSA-N |
| ZINC3938677 |
US Patents and Regulatory Information for mometasone furoate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck Sharp Dohme | ASMANEX TWISTHALER | mometasone furoate | POWDER;INHALATION | 021067-002 | Feb 1, 2008 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Intersect Ent Inc | SINUVA | mometasone furoate | IMPLANT;IMPLANTATION | 209310-001 | Dec 8, 2017 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Glenmark Generics | MOMETASONE FUROATE | mometasone furoate | OINTMENT;TOPICAL | 078571-001 | May 28, 2008 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for mometasone furoate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merck Sharp Dohme | NASONEX | mometasone furoate | SPRAY, METERED;NASAL | 020762-001 | Oct 1, 1997 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Merck Sharp Dohme | ASMANEX TWISTHALER | mometasone furoate | POWDER;INHALATION | 021067-001 | Mar 30, 2005 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Merck Sharp Dohme | ASMANEX TWISTHALER | mometasone furoate | POWDER;INHALATION | 021067-001 | Mar 30, 2005 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for mometasone furoate
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Mexico | 9203396 | ➤ Try a Free Trial |
| Czech Republic | 9300383 | ➤ Try a Free Trial |
| South Africa | 9107148 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for mometasone furoate
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 5/1998 | Austria | ➤ Try a Free Trial | PRODUCT NAME: MOMETASON FUROAT MONOHYDRAT |
| C/GB97/064 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410 |
| 0012 | Netherlands | ➤ Try a Free Trial | 980012, 20110905, EXPIRES: 20160905 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: